AANEM Practice News Express

AANEM News Express

Myasthenia Gravis Treated with Autologous Hematopoietic Stem Cell Transplantation

    12/14/2016
This study in JAMA Neurology is a retrospective case series on refractory myasthenia gravis treated by hematopoietic stem cell transplantation.

Simmons Named New Muscle & Nerve Editor-In-Chief

    11/30/2016
The AANEM is pleased to announce the selection of Zachary Simmons, MD, as the new Editor-in-Chief of Muscle & Nerve, beginning with the January 2017 issue.

Clinical Characteristics of Patients with Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin

    11/30/2016
The objective of this study in JAMA Neurology of patients with myasthenia gravis was to determine the characteristics of patients negative for both acetylcholine receptor antibodies (AchR Ab) and MuSK antibodies and positive for cortactin antibodies and compare them with seropositive patients.

2017 Physician Fee Schedule Final Rule—What Does This Rule Mean for Reimbursement?

    11/30/2016
On November 2, 2016, the Center for Medicare and Medicaid Services (CMS) issued the final rule updating payment policies and payment rates for physicians under the Medicare Physician Fee Schedule (MPFS) for 2017. Following is a summary of some of the changes affecting reimbursement for AANEM members for the calendar year (CY) 2017.

MACRA Resources For Members Available

    11/30/2016
After reviewing all 2398 pages of the final MACRA rule, AANEM policy staff have worked diligently to create resources for members to help them understand the key provisions of this complex ruling and how it will affect their practices.

CMS Releases Final Rule: 2017 Medicare Physician Fee Schedule

    11/16/2016
On November 2, 2016, the Centers for Medicare & Medicaid Services (CMS) issued the
final rule updating payment policies and payment rates for physicians under the Medicare Physician Fee Schedule (MPFS) for 2017.  CMS estimates a 0% impact in payment on neurology and physical medicine and rehabilitation physicians.

Updates to AANEM Disciplinary Policies and Procedures

    11/16/2016
Under the direction of David A. Simpson, DO, and Raghav Govindarajan, MD, the Ethics and Peer Review Committee has updated, and the AANEM Board of Directors has approved, the AANEM Disciplinary Policies and Procedures. The procedures were initially adopted in 1995 to enable fair and impartial review of complaints of professional misconduct concerning AANEM members, and, when appropriate, to pursue disciplinary action.

Learn About NCS Normal Values Through Podcast & Publications

    11/16/2016
The AANEM Normative Data Taskforce (NDTF) reports on establishing high quality reference values for nerve conduction studies (NCSs) were published in the September issue of Muscle & Nerve. Because there are not uniform standards for NCSs in the United States, taskforce members reviewed over 7500 articles to identify high quality studies regarding nerve conduction techniques and reference values for commonly tested upper and lower limb nerves. Following the publications, Ted M. Burns, MD, of the AANEM Podcast Editorial Board interviewed NDTF Chair Timothy R. Dillingham, MD.

Rate of Disease Progression: A Prognostic Biomarker in ALS

    11/16/2016
While the conclusion that a faster rate of progression at initial assessment of a patient with ALS portends a poorer prognosis is intuitive, this study in the Journal of Neurology, Neurosurgery & Psychiatry provides more precise quantification of this phenomenon.

What Does the Election Mean for Healthcare in the U.S.?

    11/16/2016
Long before the first vote was cast in the November election, it was apparent that 2017 would bring big changes to Capitol Hill. Retirements by senior lawmakers as well as self-imposed term-limits for committee leadership will change the complexion of key committees with jurisdiction over healthcare. 


First
Prev
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
...
Next
Last

Advertisement

ABEM

Advertisement

TPP

Advertisement

Find Your Dream Job